Baronsmead Second VCT half-year results: why NAV fell 9.3% and why shareholders should not ignore the rebound
Baronsmead Second Venture Trust PLC has had a rough half-year on paper, with net asset value, or NAV, per share falling 9.3% to 47.0p in the six months to 31 March 2026. For a VCT – a Venture Capital Trust that invests in smaller growth companies and offers tax perks to qualifying investors – that is clearly not the sort of update income-focused shareholders want to see.
That said, this was not a story of the portfolio falling apart across the board. The chair is pretty clear that geopolitical stress, a sharp tech sell-off and a rethink of software valuations linked to artificial intelligence did a lot of the damage. The really important detail is that NAV had already recovered to 49.95p by 31 May 2026.
Baronsmead Second VCT key numbers: NAV, dividend, fundraising and investment activity
| Metric | Six months to 31 March 2026 | Comparative |
|---|---|---|
| NAV per share | 47.0p | 51.8p at 1 October 2025 |
| NAV per share change | -9.3% | -7.1% in March 2025 period |
| NAV total return | 310.5p | 314.3p in March 2025 |
| Net assets | £197.5 million | £204.7 million |
| Funds raised | £16.5 million | £13.8 million |
| New investments | £11.1 million | £3.8 million |
| Realisation proceeds | £8.2 million | £0.3 million |
| Interim dividend declared | 1.75p per share | Not disclosed for comparison in this announcement |
There is a mixed message here. The valuation drop is bad, obviously, but fundraising, deployment and exits were all quite active. That matters because VCTs need fresh cash to keep backing portfolio companies, while profitable exits help fund dividends.
Why Baronsmead Second VCT NAV dropped: Iran war, oil market risks and AI-driven SaaS valuation cuts
The company points to two main issues. First, heightened geopolitical uncertainty, including the Iran war and knock-on worries around the oil market, inflation and global supply chains. Second, a heavy sell-off in equity markets, particularly in business software.
The software point is the one retail investors should really focus on. SaaS, or Software as a Service, businesses are often valued using revenue multiples based on listed peers. If the market suddenly decides those peers deserve lower multiples because AI could disrupt older subscription models, that ripples straight through into valuations – even if the underlying businesses are still trading reasonably well.
That seems to be exactly what happened here. Baronsmead says the biggest hit came in certain growth-stage software investments, and that its portfolio has become more sensitive as it has tilted more towards earlier-stage growth businesses.
My take: this is painful, but it is not unusual for growth-heavy portfolios. The risk is not just weak trading – it is that valuation methods themselves move against you. When that happens, NAV can fall faster than operating performance would suggest.
Portfolio performance breakdown: unquoted resilience, AIM weakness and collective funds under pressure
The underlying portfolio was not equally weak across the board.
- Unquoted portfolio: £64 million, 33% of NAV, down 1%
- AIM-traded companies: £67 million, 34% of NAV, down 14%
- Collective investment vehicles: £57 million, 29% of NAV, down 10%
- Liquid assets: £9 million, 4% of NAV, up 2%
That is actually an important split. The unquoted book held up far better than the listed and fund exposure, which tells you public market sentiment was the main short-term problem. Even so, the board admits unquoted performance has been an issue for shareholders and says it is working with the manager to improve and sustain it.
Among the positives, Equipsme and Orri performed well thanks to good trading momentum and revenue growth. On the downside, Counting Ltd and Pointr were hit by lower quoted comparable multiples and weaker commercial activity.
The direct AIM portfolio returned -14.5% in the period. That is ugly. But the company also says most portfolio companies reported trading in line with or ahead of expectations, which suggests a gap opened up between share prices and business performance.
Post-period NAV recovery to 49.95p: is the worst already in the price?
This is the most encouraging line in the whole release. After the half-year end, NAV rose to 49.35p at 30 April 2026 and then to 49.95p at 31 May 2026.
The listed portfolio and collective investment vehicles also bounced sharply in April and May. That does not erase the first-half damage, but it does support the board’s argument that the March valuation did not fully reflect the fundamentals of many investee companies.
In plain English, the market may have panicked first and thought a bit harder later.
Baronsmead Second VCT dividend remains intact, but investors should read the small print
The board has declared an interim dividend of 1.75p per share, payable on 7 September 2026 to shareholders on the register on 7 August 2026. That will be welcome news for VCT investors who buy these vehicles partly for tax-free income.
The board says it is aiming for an annual yield of 7.0% based on the opening NAV for the year, but it also stresses this is not guaranteed. That caveat matters. Dividends depend on profitable realisations, and while the Idox exit was excellent, not every exit is going to look like that.
Investment activity and exits: strong deployment, one standout winner and one weak sale
Baronsmead invested £11.1 million during the half year, including three new investments and eight follow-ons. New holdings included Tembo Money at £1.7 million, Veremark at £2.0 million and Vulcan Two Group at £0.8 million.
Follow-on backing was even more significant at £6.5 million. That tells you the manager is still supporting existing companies rather than pulling in the reins.
On realisations, the standout was Idox. The takeover by Long Path Partners generated £7.8 million of proceeds and a gross money multiple of 7.6x original cost. That is exactly the kind of winner VCT investors need.
But the IWP sale was poor, bringing in only £0.4 million and a gross money multiple of 0.25x original cost, with only modest potential upside from an earn-out. That is the VCT game in one line – some winners, some disappointments.
Fundraising strength and VCT rule changes give Baronsmead extra firepower
One of the better signs in this update is demand from investors. The company raised £16.5 million in the 2025/26 tax year, then a further £0.3 million after the period end, taking the total to £16.8 million. It also welcomed 650 new shareholders.
That gives the trust flexibility, especially as the Chancellor expanded EIS and VCT investment limits in November 2025. The company says that has already helped, particularly on quoted deployment. More room to follow on into good companies for longer is a genuine positive.
What this Baronsmead Second VCT update means for retail investors
This is a bruising half-year report, but not a disastrous one. The headline NAV fall is negative, and there is no point pretending otherwise. If you own this for capital stability, this update will not comfort you.
But if you own it as a long-term VCT with a diversified mix of quoted and unquoted UK growth businesses, there are some better signals underneath. Fundraising is healthy, the company is still investing, the Idox exit was strong, the dividend continues, and the post-period NAV recovery suggests sentiment was worse than fundamentals.
The biggest watchpoint from here is simple: can the manager improve unquoted performance while navigating the AI-driven valuation reset in software? If it can, March may end up looking like a nasty but temporary markdown. If not, shareholders may have to get used to more volatility.
For now, I would call this a cautious hold-style update rather than a clean bill of health. There is enough here to stop existing investors panicking, but not enough to say the hard part is over.
